reference/22803661

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22803661

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	789
issn	1476-5594 0950-9232
issueIdentifier	7
pageRange	781-789
publicationName	Oncogene
startingPage	781
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_df772417c12a32711be3ddbd1f06dbdd http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d5a2a254268eda1e4c837cef81a8fcc3 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c1b81fa3ca46d4d39d0ec870266374fa
bibliographicCitation	Zhan Y, Modi N, Stewart AM, Hieronimus RI, Liu J, Gutmann DH, Chadee DN. Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer. Oncogene. 2011 Feb 17;30(7):781–9. PMID: 20890305; PMCID: PMC3017676.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_573f5a7f7113401cf21a06d94d91beac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82cca5495746c6d9444350184721a688 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb8f940759b284b41d48228bf8b2645c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62b04798c762d0de67c376c54e1c90a9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc563db0fb605bcd7be4b6c7a9cfec37 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6749f7c0ea52ba5f53390d36f17d91c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_825e887477efed142f61a865d7d13eef
date	2010-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1038/onc.2010.453 https://pubmed.ncbi.nlm.nih.gov/20890305 https://pubmed.ncbi.nlm.nih.gov/PMC3017676
isPartOf	https://portal.issn.org/resource/ISSN/1476-5594 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6325 https://portal.issn.org/resource/ISSN/0950-9232
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Regulation of mixed lineage kinase 3 is required for Neurofibromatosis-2-mediated growth suppression in human cancer
discusses	http://id.nlm.nih.gov/mesh/M0328159 http://id.nlm.nih.gov/mesh/M0328033 http://id.nlm.nih.gov/mesh/M0362614 http://id.nlm.nih.gov/mesh/M0027004 http://id.nlm.nih.gov/mesh/M0217356 http://id.nlm.nih.gov/mesh/M0328280
hasSubjectTerm	http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112 http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103 http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9878 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0e1ea59185d243f44377d33dda2f0a77 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_612493bd7c441ae534b4a8e406d2549a http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.11.24 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_26abe9b86cabea57fed28bed27712278

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4771 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID998 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4296

Total number of triples: 50.